Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.

Balsamo M, Vermi W, Parodi M, Pietra G, Manzini C, Queirolo P, Lonardi S, Augugliaro R, Moretta A, Facchetti F, Moretta L, Mingari MC, Vitale M.

Eur J Immunol. 2012 Jul;42(7):1833-42. doi: 10.1002/eji.201142179. Epub 2012 May 25.

2.

Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.

Della Chiesa M, Romeo E, Falco M, Balsamo M, Augugliaro R, Moretta L, Bottino C, Moretta A, Vitale M.

Eur J Immunol. 2008 Aug;38(8):2284-9. doi: 10.1002/eji.200838434.

3.

Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.

Castriconi R, Dondero A, Augugliaro R, Cantoni C, Carnemolla B, Sementa AR, Negri F, Conte R, Corrias MV, Moretta L, Moretta A, Bottino C.

Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12640-5. Epub 2004 Aug 16.

4.

CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.

Marcenaro E, Augugliaro R, Falco M, Castriconi R, Parolini S, Sivori S, Romeo E, Millo R, Moretta L, Bottino C, Moretta A.

Eur J Immunol. 2003 Dec;33(12):3367-76.

5.

Selective cross-talk among natural cytotoxicity receptors in human natural killer cells.

Augugliaro R, Parolini S, Castriconi R, Marcenaro E, Cantoni C, Nanni M, Moretta L, Moretta A, Bottino C.

Eur J Immunol. 2003 May;33(5):1235-41.

6.

Natural killer lymphocytes: "null cells" no more.

Moretta A, Bottino C, Sivori S, Marcenaro E, Castriconi R, Della Chiesa M, Carlomagno S, Augugliaro R, Nanni M, Vitale M, Millo R.

Ital J Anat Embryol. 2001 Oct-Dec;106(4):335-42. Review.

PMID:
12003235
7.

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.

Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, Sivori S, Landi E, Biassoni R, Notarangelo LD, Moretta L, Moretta A.

J Exp Med. 2001 Aug 6;194(3):235-46. Erratum in: J Exp Med 2001 Sep 3;194(5):following 703.

8.
9.

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.

Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, Ochs HD, Wolf H, Bonnefoy JY, Biassoni R, Moretta L, Notarangelo LD, Moretta A.

J Exp Med. 2000 Aug 7;192(3):337-46.

10.

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.

Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, Marcenaro E, Accame L, Malaspina A, Biassoni R, Bottino C, Moretta L, Moretta A.

J Exp Med. 1999 Nov 15;190(10):1505-16.

11.

Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells.

Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, Castriconi R, Vitale M, Pende D, Sivori S, Millo R, Biassoni R, Moretta L, Moretta A.

Eur J Immunol. 1999 Oct;29(10):3148-59.

12.

Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells.

Falco M, Biassoni R, Bottino C, Vitale M, Sivori S, Augugliaro R, Moretta L, Moretta A.

J Exp Med. 1999 Sep 20;190(6):793-802.

13.

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.

Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, Parolini S, Moretta L, Moretta A, Biassoni R.

J Exp Med. 1999 Mar 1;189(5):787-96.

14.

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.

Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A.

J Exp Med. 1998 Jun 15;187(12):2065-72.

15.

p46, a novel natural killer cell-specific surface molecule that mediates cell activation.

Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, Moretta L, Moretta A.

J Exp Med. 1997 Oct 6;186(7):1129-36.

16.

A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.

Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, Morelli L, Augugliaro R, Semenzato G, Biassoni R, Moretta L, Moretta A.

Eur J Immunol. 1996 Aug;26(8):1816-24.

PMID:
8765026
17.

Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.

Vitale M, Sivori S, Pende D, Augugliaro R, Di Donato C, Amoroso A, Malnati M, Bottino C, Moretta L, Moretta A.

Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1453-7.

18.

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L.

J Exp Med. 1995 Sep 1;182(3):875-84.

19.

p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.

Poggi A, Pella N, Morelli L, Spada F, Revello V, Sivori S, Augugliaro R, Moretta L, Moretta A.

Eur J Immunol. 1995 Feb;25(2):369-76.

PMID:
7875198
20.
21.

Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.

Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, Moretta L.

J Exp Med. 1994 Aug 1;180(2):545-55.

23.

Identification of a new surface molecule involved in the mechanism of cell to cell adhesion between human NK and tumor target cells.

Tripodi G, Poggi A, Orengo AM, Pella N, Vitale M, Sivori S, Bottino C, Morelli L, Barbaresi M, Revello V, Augugliaro R, Moretta A.

Cytotechnology. 1993 Jan;11(Suppl 1):S109-11. doi: 10.1007/BF00746071. No abstract available.

PMID:
22358670
24.

Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery.

Moretta A, Bottino C, Tripodi G, Vitale M, Pende D, Morelli L, Augugliaro R, Barbaresi M, Ciccone E, Millo R, et al.

Int J Cancer Suppl. 1992;7:6-10.

PMID:
1428407
25.
26.

Biochemical characterization of NK-subset specific triggering surface molecules.

Bottino C, Augugliaro R, Morelli L, Orengo AM, Tripodi G, Moretta A.

Cytotechnology. 1991 Feb;5(Suppl 1):122-5. doi: 10.1007/BF00736827. No abstract available.

PMID:
22358973

Supplemental Content

Loading ...
Support Center